| abstract |
Disclosed are compositions and methods associated with or derived from anti-CCR2 antibodies. More specifically, human antibodies that bind to complete CCR2, CCR2 binding fragments and derivatives of such antibodies, and CCR2 binding polypeptides comprising such fragments are disclosed. Still further, nucleic acids and polypeptides encoding such antibodies, antibody fragments and derivatives, cells containing such polynucleotides, methods for producing such antibodies, antibody fragments and derivatives and polypeptides and such antibodies, Also disclosed are methods of using the polypeptides, including antibody fragments and derivatives and methods of treating or diagnosing a subject having a CCR2-related disorder or condition. |